Observational studyFrontiers in immunology2021

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.

Pablo Aliaga-Gaspar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.